| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2185-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35252-1mg | |||
| Carrier-Free | NBP2-35252-100ug | |||
| Carrier-Free | NBP2-35252-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35111-1mg | |||
| Carrier-Free | NBP2-35111-100ug | |||
| Carrier-Free | NBP2-35111-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2700-0.025mg | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Biotin | NBP1-28164 | |||
| PE | NBP1-28165 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP1-22408-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-06616-50ul | |||
![Western Blot: IL-10 Antibody (3C12C12) [NB100-2185] - Analysis using IL10 mouse mAb against IL10 recombinant protein.](http://images.novusbio.com/fullsize/IL-10-Antibody-3C12C12-Western-Blot-NB100-2185-img0004.jpg "Western Blot: IL-10 Antibody (3C12C12) [NB100-2185] - Analysis using IL10 mouse mAb against IL10 recombinant protein.")
![Flow Cytometry: CD4 Antibody (3-4F4) [NBP1-28258] - Cat phenotyping. The whole blood cells from the cat were washed and incubated at 4degree with the antibody. It helped characterize Tcell population in the species.This image was submitted via customer review. Image from the Allophycocyanin version of this antibody.](http://images.novusbio.com/fullsize/CD4-Antibody-3-4F4-Flow-Cytometry-NBP1-28258-img0004.jpg "Flow Cytometry: CD4 Antibody (3-4F4) [NBP1-28258] - Cat phenotyping. The whole blood cells from the cat were washed and incubated at 4degree with the antibody. It helped characterize Tcell population in the species.This image was submitted via customer review. Image from the Allophycocyanin version of this antibody.")
![Flow Cytometry: CD4 Antibody (3-4F4) [NBP1-28258] - Analysis using the FITC conjugate of NBP1-28258. Multiple staining of peripheral lymphocytes.](http://images.novusbio.com/fullsize/CD4-Antibody-3-4F4-Flow-Cytometry-NBP1-28258-img0002.jpg)
![Flow Cytometry: CD4 Antibody (3-4F4) [NBP1-28258] - Analysis using the FITC conjugate of NBP1-28258. Double staining of 1 ug/10^6 Peripheral blood mononuclear cells from a healthy domestic cat with mouse anti-feline CD4-FITC and mouse anti-feline CD8-R-PE.](http://images.novusbio.com/fullsize/CD4-Antibody-3-4F4-Flow-Cytometry-NBP1-28258-img0003.jpg)
![SDS-Page: Rat IL-4 Protein [NBP2-35252]](http://images.novusbio.com/fullsize/Rat-IL-4-Protein-SDS-Page-NBP2-35252-img0001.jpg "SDS-Page: Rat IL-4 Protein [NBP2-35252]")
![Bioactivity: Recombinant Rat IL-4 Protein [NBP2-35252] - Gene expression of macrophages. Culturing with IL-4 increased Arg1 without affecting iNOS or IL-6. Rat macrophages were cultured with M-CSF. After maturation (7 days) in vitro, macrophages were cultured with with IL-4 + M-CSF or M-CSF alone. Changes in gene expression were assayed using RT-PCR using Image from verified customer review.](http://images.novusbio.com/fullsize/Recombinant-Rat-IL-4-Protein-Bioactivity-NBP2-35252-img0002.jpg)
![SDS-Page: Mouse IL-2 Protein [NBP2-35111]](http://images.novusbio.com/fullsize/Mouse-IL-2-Protein-SDS-Page-NBP2-35111-img0001.jpg "SDS-Page: Mouse IL-2 Protein [NBP2-35111]")
![Flow Cytometry: MHC Class II antigen I A beta 1 Antibody (25-9-3) [NBP1-28162] - Analysis using the PE conjugate of NBP1-28162. Multiple staining of C57BL/6 splenocytes.](http://images.novusbio.com/fullsize/MHC-Class-II-antigen-I-A-beta-1-Antibody-25-9-3-Flow-Cytometry-NBP1-28162-img0004.jpg "Flow Cytometry: MHC Class II antigen I A beta 1 Antibody (25-9-3) [NBP1-28162] - Analysis using the PE conjugate of NBP1-28162. Multiple staining of C57BL/6 splenocytes.")
![Immunohistochemistry-Paraffin: IFN-gamma R1/CD119 Antibody (RM0093-7K23) [NBP1-22408] - The Kidney tissue samples from the Folic Acid induced kidney injury model were fixed using 4% PFA at 4C for overnight and embeded in paraffin. 4um section was sublected to IHC with NBP1-22408](http://images.novusbio.com/fullsize/IFN-gamma-R1-CD119-Antibody-RM0093-7K23-Immunohistochemistry-Paraffin-NBP1-22408-img0001.jpg "Immunohistochemistry-Paraffin: IFN-gamma R1/CD119 Antibody (RM0093-7K23) [NBP1-22408] - The Kidney tissue samples from the Folic Acid induced kidney injury model were fixed using 4% PFA at 4C for overnight and embeded in paraffin. 4um section was sublected to IHC with NBP1-22408")
![Flow Cytometry: Mouse CCR9 mAb (C9Mab-1) [NBP3-14623] - Flow cytometry surface staining pattern of human peripheral whole blood stained using anti-human CD199 (C9Mab-1) purified antibody (concentration in sample 0.5 ug/ml, GAM APC).](http://images.novusbio.com/fullsize/antibody/nbp3-14623_mouse-ccr9-mab-c9mab-1-flow-cytometry-1212202414204..jpg "Flow Cytometry: Mouse CCR9 mAb (C9Mab-1) [NBP3-14623] - Flow cytometry surface staining pattern of human peripheral whole blood stained using anti-human CD199 (C9Mab-1) purified antibody (concentration in sample 0.5 ug/ml, GAM APC).")
![Flow Cytometry: Mouse CCR9 mAb (C9Mab-1) [NBP3-14623] - Separation of human CD20 positive lymphocytes (red-filled) from CD20 negative CD199 negative lymphocytes (black-dashed) in flow cytometry analysis (surface staining) of human peripheral whole blood stained using anti-human CD199 (C9Mab-1) purified antibody (concentration in sample 0.5 ug/ml, GAM APC).](http://images.novusbio.com/fullsize/antibody/nbp3-14623_mouse-ccr9-mab-c9mab-1-flow-cytometry-12122024141531.jpg)
![Flow Cytometry: Mouse CCR9 mAb (C9Mab-1) [NBP3-14623] - Flow cytometry multicolor surface staining pattern of human lymphocytes using anti-human CD199 (C9Mab-1) purified antibody (concentration in sample 0.5 ug/ml, GAM APC) and anti-human CD20 (2H7) Pacific Blue™ antibody (4 μl reagent / 100 μl of peripheral whole blood).](http://images.novusbio.com/fullsize/antibody/nbp3-14623_mouse-ccr9-mab-c9mab-1-flow-cytometry-12122024141756..jpg)
![Flow Cytometry: ITCH/AIP4 Antibody (01) [NBP3-06616] - Analysis of Human ITCH expression on HeLa cells. The cells were treated, stained with purified anti-Human ITCH, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.](http://images.novusbio.com/fullsize/ITCH-AIP4-Antibody-01-Flow-Cytometry-NBP3-06616-img0002.jpg "<b>Biological Strategies Validation. </b>Flow Cytometry: ITCH/AIP4 Antibody (01) [NBP3-06616] - Analysis of Human ITCH expression on HeLa cells. The cells were treated, stained with purified anti-Human ITCH, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.")
![<b>Biological Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: ITCH/AIP4 Antibody (01) [NBP3-06616] - Staining of Human ITCH in Hela cells. Cells were fixed with 4% PFA, permeabilzed with 1% Triton X-100 in PBS, blocked with 10% serum, and incubated with NBP3-06616 antibody (1:60) at 37? 1 hour. Then cells were stained with the Alexa Fluor 488-conjugated Goat Anti-mouse IgG secondary antibody (green) and counterstained with DAPI (blue). Positive staining was localized to cytoplasm.](http://images.novusbio.com/fullsize/nbp3-06616_mouse-monoclonal-itch-aip4-antibody-01-23520251433151.png)